ClinicalTrials.Veeva

Menu

Continuation of Aspirin Before Isolated Heart Valve Surgery

U

University of Liege

Status

Unknown

Conditions

Isolated Heart Valve Surgery

Treatments

Drug: Aspirin

Study type

Observational

Funder types

Other

Identifiers

NCT05151796
ulganescardio_aspirine

Details and patient eligibility

About

Whether or not continuing aspirin up to de day before surgery increases the risk of bleeding and/or prevents thrombo-embolic complications remains debated. The investigators retrospectively investigated the whether continuing aspirine within 5 days of isolated heart valve surgery increased the risk of bleeding.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Isolated heart valve surgery

Exclusion criteria

  • Antiplatelet agent other than aspirin or anticoagulant not discontinued preoperatively
  • Emergent or salvage surgery
  • Surgery for endocarditis
  • Use of NSAIDs within 48 hours before surgery

Trial design

500 participants in 2 patient groups

Aspirin continued within 5 days before surgery
Treatment:
Drug: Aspirin
Aspirin discontinued more than 5 days before surgery

Trial contacts and locations

1

Loading...

Central trial contact

Gregory Hans, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems